Shaanxi Kanghui Pharm Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 0.01%

Shaanxi Kanghui Pharm Co Ltd (603139) has an Asset Resilience Ratio of 0.01% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥252.20K
≈ $36.90K USD Cash + Short-term Investments

Total Assets

CN¥1.71 Billion
≈ $249.51 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how Shaanxi Kanghui Pharm Co Ltd's Asset Resilience Ratio has changed over time. Check Shaanxi Kanghui Pharm Co Ltd (603139) strategic investment index to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Shaanxi Kanghui Pharm Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Shaanxi Kanghui Pharm Co Ltd (603139) total market value.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥252.20K 0.01%
Total Liquid Assets CN¥252.20K 0.01%

Asset Resilience Insights

  • Limited Liquidity: Shaanxi Kanghui Pharm Co Ltd maintains only 0.01% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Shaanxi Kanghui Pharm Co Ltd Industry Peers by Asset Resilience Ratio

Compare Shaanxi Kanghui Pharm Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Drug Manufacturers - Specialty & Generic 0.20%
JW Pharmaceutical Corp
KO:001067
Drug Manufacturers - Specialty & Generic 8.17%
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
Drug Manufacturers - Specialty & Generic 0.16%
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
Drug Manufacturers - Specialty & Generic 11.60%
Guilin Sanjin Pharmaceutical Co Ltd
SHE:002275
Drug Manufacturers - Specialty & Generic 14.80%
Fuan Pharmaceutical Group Co
SHE:300194
Drug Manufacturers - Specialty & Generic 1.34%
DRI Healthcare Trust
TO:DHT-U
Drug Manufacturers - Specialty & Generic 13.91%
Hainan Shuangcheng Pharmaceut
SHE:002693
Drug Manufacturers - Specialty & Generic 1.03%

Annual Asset Resilience Ratio for Shaanxi Kanghui Pharm Co Ltd (2019–2025)

The table below shows the annual Asset Resilience Ratio data for Shaanxi Kanghui Pharm Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 0.01% CN¥252.20K
≈ $36.90K
CN¥1.81 Billion
≈ $265.51 Million
-0.01pp
2024-12-31 0.02% CN¥359.18K
≈ $52.56K
CN¥1.89 Billion
≈ $276.25 Million
-0.13pp
2023-12-31 0.15% CN¥3.02 Million
≈ $441.85K
CN¥2.05 Billion
≈ $300.23 Million
-0.10pp
2022-12-31 0.25% CN¥4.50 Million
≈ $658.73K
CN¥1.82 Billion
≈ $266.57 Million
-6.18pp
2021-12-31 6.42% CN¥119.47 Million
≈ $17.48 Million
CN¥1.86 Billion
≈ $272.21 Million
+2.19pp
2020-12-31 4.23% CN¥55.47 Million
≈ $8.12 Million
CN¥1.31 Billion
≈ $191.87 Million
-12.75pp
2019-12-31 16.98% CN¥192.00 Million
≈ $28.10 Million
CN¥1.13 Billion
≈ $165.45 Million
--
pp = percentage points

About Shaanxi Kanghui Pharm Co Ltd

SHG:603139 China Drug Manufacturers - Specialty & Generic
Market Cap
$529.81 Million
CN¥3.62 Billion CNY
Market Cap Rank
#11900 Global
#3405 in China
Share Price
CN¥36.25
Change (1 day)
+3.78%
52-Week Range
CN¥20.27 - CN¥45.21
All Time High
CN¥45.21
About

Shaanxi Kanghui Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. It offers gynecological, orthopedic, dermatology, diabetes, respiratory system, urinary system, cardiovascular, tranquilizer, gastrointestinal, hepatobiliary, and other drugs in the form of tablets, capsules, granules, mixtures, teas, plasters, ointments, lin… Read more